|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-10-14
|
|
pubmed:abstractText |
To evaluate the overall survival (OS) and disease-specific survival (DSS) in men receiving primary androgen-deprivation therapy (PADT) or salvage medical ADT (SADT) for prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1208-14
|
|
pubmed:meshHeading |
pubmed-meshheading:19388987-Adult,
pubmed-meshheading:19388987-Aged,
pubmed-meshheading:19388987-Aged, 80 and over,
pubmed-meshheading:19388987-Androgen Antagonists,
pubmed-meshheading:19388987-Antineoplastic Agents, Hormonal,
pubmed-meshheading:19388987-Cause of Death,
pubmed-meshheading:19388987-Goserelin,
pubmed-meshheading:19388987-Humans,
pubmed-meshheading:19388987-Male,
pubmed-meshheading:19388987-Middle Aged,
pubmed-meshheading:19388987-Neoplasms, Hormone-Dependent,
pubmed-meshheading:19388987-Prostatic Neoplasms,
pubmed-meshheading:19388987-Retrospective Studies,
pubmed-meshheading:19388987-Salvage Therapy,
pubmed-meshheading:19388987-Survival Analysis,
pubmed-meshheading:19388987-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
|
|
pubmed:affiliation |
Department of Urology, University of Tennessee Health Science Center, Memphis, TN, USA. christopher.diblasio@mountsinai.org
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
